How the Wegovy Pen Works: What Happens From Cap to Click

Each Wegovy pen is pre-filled with four weeks of doses and delivers semaglutide into the subcutaneous (under-skin) fat layer via a concealed, auto-inserting needle.
The dose escalation schedule runs from 0.25 mg up to 2.4 mg (or 7.2 mg with the newer high-dose pen), with each step guided by your prescriber at roughly four-week intervals.
Injection sites are rotated across the abdomen, thigh, or upper arm; the same site should not be used two weeks running to reduce local irritation.
Pens must be stored in the refrigerator at 2–8 °C until first use; refer to your Patient Information Leaflet for the exact room-temperature window before discarding an unrefrigerated pen.

The Wegovy pen delivers a pre-measured dose of semaglutide — a GLP-1 receptor agonist — through a short, fine needle into the fat just beneath the skin. Each injection is once weekly, and the pen itself is designed so that the needle is never visible during use. Wegovy is a prescription-only medicine, meaning a clinical assessment must confirm it is appropriate for you before treatment begins. This page explains exactly what the device does, how to use it safely, and what to expect at each stage of your dose journey, drawn from the NHS's patient guidance on semaglutide and the Wegovy SmPC.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A clear walkthrough of the Wegovy pen, device, technique, and dose progression

What does the pen actually contain, and how does it release the medicine?

Each Wegovy pen is a single-patient pre-filled injector. Inside the barrel sits a cartridge of liquid semaglutide. When you press the pen against your skin and activate it, a spring mechanism drives the needle forward (you won't see it) and automatically delivers the full pre-set dose before retracting. There is nothing to draw up, no separate needle to attach for routine injections, and no dial to twist to the right number. The device removes most of the steps that people find anxiety-inducing about self-injection.

The pen is disposable. Once a four-week supply of doses is complete, it is spent and should go into a sharps container rather than household rubbish. A new pen begins the next period of treatment. If you want a broader look at the different Wegovy pen formats available, including the newer 7.2 mg single-dose device approved by the MHRA in April 2026, that page covers the distinctions in detail.

The concealed needle is short and fine (typically 4–5 mm) which is why most people report less discomfort than they anticipated. If you're curious about how a Wegovy pen works mechanically, including the spring, cartridge and retraction sequence, that page walks through each stage clearly. The injection deposits semaglutide into the subcutaneous layer, where it is absorbed gradually. That slow absorption is part of why once-weekly dosing works: the drug's long half-life keeps plasma levels stable across seven days.

Which injection sites work, and does technique change the result?

Three areas are licensed injection sites: the abdomen (avoiding the two-inch zone around the navel), the front of the thigh, and the outer upper arm. Rotating between them (and between spots within each area) reduces the risk of lipohypertrophy, the small lumpy deposits of fat that can form when the same point is used repeatedly. Lumpy tissue absorbs medicine less reliably, so rotation is practical as well as cosmetic.

Before injecting, wipe the chosen spot with an alcohol swab and allow it to dry completely, wet alcohol stings more and marginally affects sterility. Press the pen firmly flat against the skin, activate it, then hold it in place for several seconds after the click. Lifting it too early is the most common cause of incomplete delivery. If you notice a droplet on the skin afterwards, the full dose may not have been absorbed; note it in your injection log and mention it to your prescriber at the next check-in.

A quick checking habit worth building: before every injection, tilt the pen and look through the viewing window. The liquid should be clear and colourless. Any cloudiness, particles, or discolouration means the pen should not be used, contact your prescriber or pharmacist that day. This takes under a minute and catches the rare case of a compromised cartridge. For a fuller account of how semaglutide works inside the body once it's absorbed, this page on the mechanism of semaglutide injections goes deeper into the biology.

How does the dose change over time, and who decides when to step up?

Wegovy's dose schedule is a gradual escalation designed to let your body adjust to semaglutide before reaching the maintenance level. Treatment opens at 0.25 mg weekly, this is not the therapeutic dose; it is a settling-in period aimed at reducing the nausea and digestive effects that hit hardest when the medicine is new. Steps move through 0.5 mg, 1.0 mg, 1.7 mg, and then 2.4 mg, with roughly four weeks at each level. If you'd like to understand how Wegovy pens work across the different dose strengths, including what changes between devices at each step, that page covers the full escalation range. The MHRA's approval of a dedicated 7.2 mg pen in April 2026 adds a further optional step for eligible adults, subject to prescriber assessment.

Your prescriber decides when to move up, not the calendar alone. If a particular dose is causing significant side effects, the standard clinical approach is to stay at that level longer rather than push through discomfort. At nume, every repeat order receives a clinical review before dispatch, which is the point at which dose progression is assessed. There are no automatic step-ups.

Side effects during escalation are typically gastrointestinal: nausea, loose stools, or reduced appetite that can tip into genuine discomfort. They tend to be most noticeable in the first week or two at a new dose, then settle. Persistent or severe symptoms (particularly intense stomach pain that moves into the back) need prompt medical attention. The MHRA Yellow Card scheme allows patients to report any suspected side effects directly to the regulator, which helps build the post-market safety picture for newer medicines like Wegovy.

Cost context sits alongside all of this practically. Private Wegovy pricing varies by dose and provider; if you are weighing up what the treatment commitment actually involves financially, this overview of Wegovy costs in the UK sets out what legitimate pricing typically covers and what to watch for.

What should you do if you miss a dose or the pen malfunctions?

Missing a single weekly injection does happen. The detail of what to do (whether to inject as soon as you remember or skip to the next scheduled day) depends on how many days have passed, and the right answer is in your Patient Information Leaflet and with your prescriber, not in a general content page. What is consistent across GLP-1 medicines is that doubling up to compensate is not appropriate.

Pen malfunctions are uncommon but not unknown. If the pen clicks without resistance, fails to click at all, or the dose counter does not advance, do not attempt a second injection assuming the first failed. Contact your prescriber or the nume support team to talk through what happened before the next dose. Keeping the original box with the batch number makes any product quality query easier to resolve. Spare replacement needles are worth having if your pen format requires needle changes, though the standard Wegovy autoinjector does not, check your specific device's instructions to confirm.

For people considering whether Wegovy is the right choice overall, or who want to understand how it compares with tirzepatide, the main Wegovy page covers eligibility, evidence and the clinical picture in full. When you are ready to discuss your own situation with a prescriber, starting a free consultation with our team is the next step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions